Abstract

Journal of Cancer Metastasis and Treatment is an open access journal, focusing on basic and clinical studies related to cancer cell, cell biology, oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc.

Highlights

  • Abnormal cell growth can be initiated through inflammation[1]

  • The cells were treated with the cytokine cocktail from PHA-stimulated Jurkat cells, and a significant increased binding of the lectins could be detected in both cell lines [Figure 2]

  • In this study we demonstrate that the sialic acid (SA)-expression of RAW 264.7 and MCF-7 cells treated with recombinant cytokines in vitro could be analyzed with the use of SA-imprinted molecularly polymers (SA-MIPs) and flow cytometry

Read more

Summary

Introduction

Abnormal cell growth can be initiated through inflammation[1]. Cancer cells are able to reshape the microenvironment by expression of tumor-promoting chemokines and cytokines[2,3]. Cytokines act as cell regulators of many different biological processes including cell growth, differentiation, metabolism, immunity and inflammation. Cytokines can enhance cancer cell growth by modulating the cellular microenvironment or by affecting the cells directly. Pro- inflammatory cytokines can be oncogenic and thereby inducing elevated levels of pro- invasive factors such as metalloproteinase-2 (MMP-2) and epithelial growth factor

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.